Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Obesity Surgery
Erschienen in: Obesity Surgery 12/2016

11.10.2016 | Review Article

The Role of the Vagal Nucleus Tractus Solitarius in the Therapeutic Effects of Obesity Surgery and Other Interventional Therapies on Type 2 Diabetes

verfasst von: Claudio Blasi

Erschienen in: Obesity Surgery | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

The current treatment for obesity-related type 2 diabetes is not able to achieve sufficient metabolic control. New remission prospects have been offered through bariatric surgery and other interventional therapies. The aim of the study is to illustrate the mechanism by which such therapies affect the autonomic system, in particular the afferent vagal activity. The first and most important terminal of this activity is the brainstem vagal nucleus tractus solitarius. Its function, on which the vagal efferent inputs that control the splanchnic organs depend, is conditioned by the level of synaptic transmission within it. In conclusion, on the basis of such a view, a selective pharmacological modulation of such transmission as the target for future medical treatment of obesity and related type 2 diabetes is proposed.
Literatur
1.
Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013;309(21):2240–9.PubMedPubMedCentralCrossRef
2.
Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311(22):2297–304.PubMedCrossRef
3.
Scott JD, Johnson BL, Blackhurst DW, et al. Does bariatric surgery reduce the risk of major cardiovascular events? A retrospective cohort study of morbidly obese surgical patients. Surg Obes Relat Dis. 2013;9(1):32–9.PubMedCrossRef
4.
Salinari S, Bertuzzi A, Asnaghi S, et al. First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care. 2009;32(3):375–80.PubMedPubMedCentralCrossRef
5.
6.
Canales BK, Gonzalez RD. Kidney stone risk following Roux-en-Y gastric bypass surgery. Transl Urol Androl. 2014;3(3):242–9.
7.
Madsbad S, Dirksen C, Holst JJ. Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery. Lancet Diabetes Endocrinol. 2014;2(2):152–64.PubMedCrossRef
8.
Tack J, Deloose E. Complications of bariatric surgery: dumping syndrome, reflux and vitamin deficiencies. Best Pract Res Clin Gastroenterol. 2014;28(4):741–9.PubMedCrossRef
9.
Hussain SS, Bloom SR. The regulation of food intake by the gut-brain axis: implications for obesity. Int J Obes. 2013;37(5):625–33.CrossRef
10.
Stefater MA, Wilson-Pérez HE, Chambers AP, et al. All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr Rev. 2012;33(4):595–622.PubMedPubMedCentralCrossRef
11.
Lutz TA, Bueter M. The physiology underlying Roux-en-Y gastric bypass: a status report. Am J Physiol Regul Integr Comp Physiol. 2014;307(11):R1275–91.PubMedPubMedCentralCrossRef
12.
Blasi C. Can diabetes heal?—from observations to perspectives. Curr Diabetes Rev. 2016;12(3):184–98.PubMedCrossRef
13.
Berthoud HR, Zheng H, Shin AC. Food reward in the obese and after weight loss induced by calorie restriction and bariatric surgery. Ann N Y Acad Sci. 2012;1264:36–48.PubMedPubMedCentralCrossRef
14.
Bach EC, Halmos KC, Smith BN. Enhanced NMDA receptor-mediated modulation of excitatory neurotransmission in the dorsal vagal complex of streptozotocin-treated, chronically hyperglycemic mice. PLoS One. 2015;10(3):e0121022.PubMedPubMedCentralCrossRef
15.
Zhao K, Ao Y, Harper RM, et al. Food-intake dysregulation in type 2 diabetic goto-kakizaki rats: hypothesized role of dysfunctional brainstem thyrotropin-releasing hormone and impaired vagal output. Neuroscience. 2013;247:43–54.PubMedPubMedCentralCrossRef
16.
Browning KR, Travagli RA. Plasticity of vagal brainstem circuits in the control of gastrointestinal function. Auton Neurosci. 2011;161(1–2):6–13.PubMedCrossRef
17.
Powley TL. Vagal circuitry mediating cephalic-phase responses to food. Appetite. 2000;34(2):184–8.PubMedCrossRef
18.
19.
de Lartigue G. Role of the vagus nerve in the development and treatment of diet-induced obesity. J Physiol. 2016;9.
20.
Thorens B, Larsen PJ. Gut-derived signaling molecules and vagal afferents in the control of glucose and energy homeostasis. Curr Opin Clin Nutr Metab Care. 2004;7(4):471–8.PubMedCrossRef
21.
22.
23.
24.
Rasoamanana R, Darcel N, Fromentin G, et al. Nutrient sensing and signaling by the gut. Proc Nutr Soc. 2012;71(4):446–55.PubMedCrossRef
25.
Punjabi M, Arnold M, Geary N, et al. Peripheral glucagon-like peptide-1 (GLP-1) and satiation. Physiol Behav. 2011;105(1):71–6.PubMedCrossRef
26.
Hayes MR, Kanoski SE, De Jonghe BC, et al. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1. Am J Physiol Regul Integr Comp Physiol. 2011;301(5):R1479–85.PubMedPubMedCentralCrossRef
27.
Burcelin R. The gut-brain axis: a major glucoregulatory player. Diabetes Metab. 2010;36(Suppl 3):S54–8.PubMedCrossRef
28.
Covasa M. CCK- and leptin-induced vagal afferent activation: a model for organ-specific endocrine modulation of visceral sensory information. Am J Physiol Regul Integr Comp Physiol. 2006;290(6):R1542–3.PubMedCrossRef
29.
30.
Ritter RC. A tale of two endings: modulation of satiation by NMDA receptors on or near central and peripheral vagal afferent terminals. Physiol Behav. 2011;105(1):94–9.PubMedPubMedCentralCrossRef
31.
Haines DE. Neuroanatomy. An atlas of structures, sections, and systems. Lippincott Williams & Wilkins; 2004.
32.
Schneeberger M, Gomis R, Claret M. Hypothalamic and brainstem neuronal circuits controlling homeostatic energy balance. J Endocrinol. 2014;220(2):T25–46.PubMedCrossRef
33.
Browning KN, Fortna SR, Hajnal A. Roux-en-Y gastric bypass reverses the effects of diet-induced obesity to inhibit the responsiveness of central vagal motoneurones. J Physiol. 2013;591(9):2357–72.PubMedPubMedCentralCrossRef
34.
Chen HS, Lipton SA. The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem. 2006;97(6):1611–26.PubMedCrossRef
35.
Browning KN, Babic T, Toti L, et al. Plasticity in the brainstem vagal circuits controlling gastric motor function triggered by corticotropin releasing factor. J Physiol. 2014;592(20):4591–605.PubMedPubMedCentralCrossRef
36.
Meyer D, Bonhoeffer T, Scheuss V. Balance and stability of synaptic structures during synaptic plasticity. Neuron. 2014;82(2):430–43.PubMedCrossRef
37.
Gerrow K, Triller A. Synaptic stability and plasticity in a floating world. Curr Opin Neurobiol. 2010;20(5):631–9.PubMedCrossRef
38.
Shouval HZ, Castellani GC, Blais BS, et al. Converging evidence for a simplified biophysical model of synaptic plasticity. Biol Cybern. 2002;87(5–6):383–91.PubMedCrossRef
39.
Wu SW, Fenwick AJ, Peters JH. Channeling satiation: a primer on the role of TRP channels in the control of glutamate release from vagal afferent neurons. Physiol Behav. 2014;136:179–84.PubMedPubMedCentralCrossRef
40.
Meldrum BS. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr. 2000;130(4S Suppl):1007S–15S.PubMed
41.
Baude A, Strube C, Tell F, et al. Glutamatergic neurotransmission in the nucleus tractus solitary: structural and functional characteristics. J Chem Neuroanat. 2009;38(3):145–53.PubMedCrossRef
42.
Gao H, Smith BN. Tonic GABAA receptor-mediated inhibition in the rat dorsal motor nucleus of the vagus. J Neurophysiol. 2010;103(2):904–14.PubMedCrossRef
43.
Davis SF, Derbenev AV, Williams KW, et al. Excitatory and inhibitory local circuit input to the rat dorsal motor nucleus of the vagus originating from the nucleus tractus solitarius. Brain Res. 2004;1017(1–2):208–17.PubMedPubMedCentralCrossRef
44.
Travagli RA, Rogers RC. Receptors and transmission in the brain-gut axis: potential for novel therapies. V. Fast and slow extrinsic modulation of dorsal vagal complex circuits. Am J Physiol Gastrointest Liver Physiol. 2001;281(3):G595–601.PubMedPubMedCentral
45.
Broussard DL, Altschuler SM. Brainstem viscerotopic organization of afferents and efferents involved in the control of swallowing. Am J Med. 2000;108(Suppl 4a):79S–86S.PubMedCrossRef
46.
Browning KN, Travagli RA. Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions. Compr Physiol. 2014;4(4):1339–68.PubMedPubMedCentralCrossRef
47.
Blake CB, Smith BN. cAMP-dependent insulin modulation of synaptic inhibition in neurons of the dorsal motor nucleus of the vagus is altered in diabetic mice. Am J Physiol Regul Integr Comp Physiol. 2014;307(6):R711–20.PubMedPubMedCentralCrossRef
48.
Ballsmider LA, Vaughn AC, David M, et al. Sleeve gastrectomy and Roux-en-Y gastric bypass alter the gut-brain communication. Neural Plast. 2015;2015:601985.PubMedPubMedCentral
49.
Kentish SJ, Page AJ. The role of gastrointestinal vagal afferent fibres in obesity. J Physiol. 2015;593(4):775–86.PubMedCrossRef
50.
51.
Daly DM, Park SJ, Valinsky WC, et al. Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse. J Physiol. 2011;589(PT 11):2857–70.PubMedPubMedCentralCrossRef
52.
53.
54.
Furnes MW, Zhao CM, Chen D. Development of obesity is associated with increased calories per meal rather than per day. A study of high-fat diet-induced obesity in young rats. Obes Surg. 2009;19(10):1430–8.PubMedCrossRef
55.
Dockray GJ, Burdyga G. Plasticity in vagal afferent neurons during feeding and fasting: mechanisms and significance. Acta Physiol (Oxf). 2011;201(3):313–21.CrossRef
56.
Page AJ. Vagal afferent dysfunction in obesity: cause or effect. J Physiol. 2016;594(1):5–6.PubMedCrossRef
57.
Kral JG, Paez W, Wolfe BM. Vagal nerve function in obesity: therapeutic implications. World J Surg. 2009;33(10):1995–2006.PubMedCrossRef
58.
Stearns AT, Balakrishnan A, Radmanesh A, et al. Relative contributions of afferent vagal fibers to resistance to diet-induced obesity. Dig Dis Sci. 2012;57(5):1281–90.PubMedCrossRef
59.
Leung FW. Capsaicin as an anti-obesity drug. Prog Drug Res. 2014;68:171–9.PubMed
60.
Westerterp-Plantenga MS, Smeets A, Lejeune MP. Sensory and gastrointestinal satiety effects of capsaicin on food intake. Int J Obes. 2005;29(6):682–8.CrossRef
61.
Faris PL, Kim SW, Meller WH, et al. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial. Lancet. 2000;355(9206):792–7.PubMedCrossRef
62.
Blackshaw LA, Grundy D. Effects of 5-hydroxytryptamine on discharge of vagal mucosal afferent fibres from the upper gastrointestinal tract of the ferret. J Auton Nerv Syst. 1993;45(1):41–50.PubMedCrossRef
63.
64.
Bonham AC, Chen CY, Sekizawa S, et al. Plasticity in the nucleus tractus solitarius and its influence on lung and airway reflexes. J Appl Physiol. 2006;101(1):322–7.PubMedCrossRef
65.
Val-Laillet D, Aarts E, Weber B, et al. Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity. Neuroimage Clin. 2015;8:1–31.PubMedPubMedCentralCrossRef
66.
Donovan MJ, Paulino G, Raybould HE. CCK(1) receptor is essential for normal meal patterning in mice fed high fat diet. Physiol Behav. 2007;92(5):969–74.PubMedPubMedCentralCrossRef
67.
Covasa M, Ritter RC. Adaptation to high-fat diet reduces inhibition of gastric emptying by CCK and intestinal oleate. Am J Physiol Regul Integr Comp Physiol. 2000;278(1):R166–70.PubMed
68.
Zsombok A, Bhaskaran MD, Gao H, et al. Functional plasticity of central TRPV1 receptors in brainstem dorsal vagal complex circuits of streptozotocin-treated hyperglycemic mice. J Neurosci. 2011;31(39):14024–31.PubMedPubMedCentralCrossRef
69.
Ricardo JA, Koh ET. Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat. Brain Res. 1978;153(1):1–26.PubMedCrossRef
70.
Rinaman L. Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure. Brain Res. 2010;1350:18–34.PubMedPubMedCentralCrossRef
71.
Ter Horst GJ, de Boer P, Luiten PG, et al. Ascending projections from the solitary tract nucleus to the hypothalamus. A Phaseolus vulgaris lectin tracing study in the rat. Neuroscience. 1989;31(3):785–97.PubMedCrossRef
72.
Jean A. Le noyau du faisceau solitaire: aspects neuroanatomiques, neurochimiques et fonctionnels. Arch Int Physiol Bioch Biophys. 1991;99:A3–A52.
73.
Van den Oever MC, Spijker S, Smit AB. The synaptic pathology of drug addiction. Adv Exp Med Biol. 2012;970:469–91.PubMedCrossRef
74.
75.
Gipson CD, Kupchik YM, Kalivas PW. Rapid, transient synaptic plasticity in addiction. Neuropharmacology. 2014;76 Pt B:276–86.PubMedCrossRef
76.
77.
Peters JH, Gallaher ZR, et al. Withdrawal and restoration of central vagal afferents within the dorsal vagal complex following subdiaphragmatic vagotomy. J Comp Neurol. 2013;521(15):3584–99.PubMedPubMedCentralCrossRef
78.
Gallaher ZR, Ryu V, Herzog T, et al. Changes in microglial activation within the hindbrain, nodose ganglia, and the spinal cord following subdiaphragmatic vagotomy. Neurosci Lett. 2012;513(1):31–6.PubMedPubMedCentralCrossRef
79.
Andreelli F, Amouyal C, Magnan C, et al. What can bariatric surgery teach us about the pathophysiology of type 2 diabetes? Diabetes Metab. 2009;35(6 Pt 2):499–507.PubMedCrossRef
80.
Karim R, Chaudhri P. Behavioral addictions: an overview. J Psychoactive Drugs. 2012;44(1):5–17.PubMedCrossRef
81.
Sussman S, Lisha N, Griffiths M. Prevalence of the addictions: a problem of the majority or the minority? Eval Health Prof. 2011;34(1):3–56.PubMedCrossRef
82.
Pang ZP, Han W. Regulation of synaptic functions in central nervous system by endocrine hormones and the maintenance of energy homoeostasis. Biosci Rep. 2012;32(5):423–32.PubMedPubMedCentralCrossRef
83.
Dunn JP, Cowan RL, Volkow ND, et al. Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings. Brain Res. 2010;1350:123–30.PubMedPubMedCentralCrossRef
84.
Breen DM, Rasmussen BA, Côté CD, et al. Nutrient-sensing mechanisms in the gut as therapeutic targets for diabetes. Diabetes. 2013;62(9):3005–13.PubMedPubMedCentralCrossRef
85.
Kullmann S, Heni M, Veit R, et al. Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults. Diabetes Care. 2015;38(6):1044–50.PubMedCrossRef
86.
Manning S, Pucci A, Batterham RL. Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms. J Clin Invest. 2015;125(3):939–48.PubMedPubMedCentralCrossRef
87.
le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007;246(5):780–5.PubMedCrossRef
88.
Larder R, O’Rahilly S. Shedding pounds after going under the knife: guts over glory-why diets fail. Nat Med. 2012;18(5):666–7.PubMedCrossRef
89.
Miras AD, le Roux CW. Mechanisms underlying weight loss after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2013;10(10):575–84.PubMedCrossRef
90.
Scott WR, Batterham RL. Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am J Physiol Regul Integr Comp Physiol. 2011;301(1):R15–27.PubMedCrossRef
91.
Bueter M, Löwenstein C, Olbers T, et al. Gastric bypass increases energy expenditure in rats. Gastroenterology. 2010;138(5):1845–53.PubMedCrossRef
92.
Schultes B, Ernst B, Wilms B, et al. Hedonic hunger is increased in severely obese patients and is reduced after gastric bypass surgery. Am J Clin Nutr. 2010;92(2):277–83.PubMedCrossRef
93.
Flancbaum L, Choban PS, Bradley LR, et al. Changes in measured resting energy expenditure after Roux-en-Y gastric bypass for clinically severe obesity. Surgery. 1997;122(5):943–9.PubMedCrossRef
94.
Delin CR, Watts JM, Saebel JL, et al. Eating behavior and the experience of hunger following gastric bypass surgery for morbid obesity. Obes Surg. 1997;7(5):405–13.PubMedCrossRef
95.
Chambers AP, Wilson-Perez HE, McGrath S, et al. Effect of vertical sleeve gastrectomy on food selection and satiation in rats. Am J Physiol Endocrinol Metab. 2012;303(8):E1076–84.PubMedPubMedCentralCrossRef
96.
Steele KE, Prokopowicz GP, Schweitzer MA, et al. Alterations of central dopamine receptors before and after gastric bypass surgery. Obes Surg. 2010;20(3):369–74.PubMedCrossRef
97.
Hao Z, Townsend RL, Mumphrey MB, et al. Vagal innervation of the intestine contributes to weight loss after Roux-e-Y gastric bypass surgery in rats. Obes Surg. 2014;24(12):2145–51.PubMedPubMedCentralCrossRef
98.
Gautron L, Zechner J, Aguirre V. Vagal innervation patterns following roux-en-Y gastric bypass in the mouse. Int J Obes. 2013;37(12):1603–7.CrossRef
99.
Yamazaki H, Tsuboya T, Tsuji K, et al. Independent association between improvement of nonalcoholic fatty liver disease and reduced incidence of type 2 diabetes mellitus. Diabetes Care. 2015;38(9):1673–9.PubMedCrossRef
100.
Yki-Järvinen H. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. Dig Dis. 2010;28(1):203–9.PubMedCrossRef
101.
Immonen H, Hannukainen JC, Iozzo P, et al. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients. J Hepatol. 2014;60(2):377–83.PubMedCrossRef
102.
Quercia I, Dutia R, Kotler DP, et al. Gastrointestinal changes after bariatric surgery. Diabetes Metab. 2014;40(2):87–94.PubMedCrossRef
103.
He B, Piao D, Yu C, et al. Amelioration in hepatic insulin sensitivity by reduced hepatic lipid accumulation at short-term after Roux-en-Y gastric bypass surgery in type 2 diabetic rats. Obes Surg. 2013;23(12):2033–41.PubMedCrossRef
104.
Taylor R. Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia. 2008;51(10):1781–9.PubMedCrossRef
105.
Yue JT, Abraham MA, LaPierre MP, et al. A fatty acid-dependent hypothalamic-DVC neurocircuitry that regulates hepatic secretion of triglyceride-rich lipoproteins. Nat Commun. 2015;6:5970.PubMedCrossRef
106.
Lam CK, Chari M, Rutter GA, et al. Hypothalamic nutrient sensing activates a forebrain-hindbrain neuronal circuit to regulate glucose production in vivo. Diabetes. 2011;60(1):107–13.PubMedCrossRef
107.
Cohen R, le Roux CW, Papamargaritis D, et al. Role of proximal gut exclusion from food on glucose homeostasis in patients with type 2 diabetes. Diabet Med. 2013;30(12):1482–6.PubMedCrossRef
108.
de Jonge C, Rensen SS, Verdam FJ, et al. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg. 2013;23(9):1354–60.PubMedCrossRef
109.
Fractyl Labs. Positive clinical data for first procedural therapy to treat type 2 diabetes. In: Abstracts from the 19th world congress of the international federation for the surgery of obesity & metabolic disorders (IFSO). Obes Surg. 2014;24(8):1170.
110.
Kamvissi V, Salerno A, Bornstein SR, et al. Incretins or anti-incretins? A new model for the “entero-pancreatic axis”. Horm Metab Res. 2015;47(1):84–7.PubMed
111.
Farré R, Tack J. Food and symptom generation in functional gastrointestinal disorders: physiological aspects. Am J Gastroenterol. 2013;108(5):698–706.PubMedCrossRef
112.
Berthoud HR, Kressel M, Raybould HE, et al. Vagal sensors in the rat duodenal mucosa: distribution and structure as revealed by in vivo DiI-tracing. Anat Embryol (Berl). 1995;191(3):203–12.CrossRef
113.
Kressel M, Berthoud HR, Neuhuber WL. Vagal innervation of the rat pylorus: an anterograde tracing study using carbocyanine dyes and laser scanning confocal microscopy. Cell Tissue Res. 1994;275(1):109–23.PubMedCrossRef
114.
Holst JJ. Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery. Curr Opin Pharmacol. 2013;13(6):983–8.PubMedCrossRef
115.
Daniel EE, Wiebe GE. Transmission of reflexes arising on both sides of the gastroduodenal junction. Am J Phys. 1966;211(3):634–42.
116.
Shikora S, Toouli J, Herrera MF, et al. Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus. J Obes. 2013;2013:245683.PubMedPubMedCentralCrossRef
117.
Val-Laillet D, Biraben A, Randuineau G, et al. Chronic vagus nerve stimulation decreased weight gain, food consumption and sweet craving in obese adult minipigs. Appetite. 2010;55(2):245–52.PubMedCrossRef
118.
Smith DK, Sarfeh J, Howard L. Truncal vagotomy in hypothalamic obesity. Lancet. 1983;1(8337):1330–1.PubMedCrossRef
119.
Lebovitz HE, Ludvik B, Yaniv I, et al. Gutterman DD; Metacure Investigators. Treatment of patients with obese type 2 diabetes with Tantalus-DIAMOND® gastric electrical stimulation: normal triglycerides predict durable effects for at least 3 years. Horm Metab Res. 2015;47(6):456–62.PubMedCrossRef
120.
Peles S, Petersen J, Aviv R, et al. Enhancement of antral contractions and vagal afferent signaling with synchronized electrical stimulation. Am J Physiol Gastrointest Liver Physiol. 2003;285(3):G577–85.PubMedCrossRef
121.
Goldman JM, Wheeler MF. Remission of diabetes after irradiation of head and neck. Diabetes Care. 1987;10(1):137–8.PubMedCrossRef
122.
Raheja BS, Motwani BT, Mehta AR, et al. Remission of NIDDM after irradiation of metastatic cervical lymph nodes. Diabetes Care. 1986;9(1):101–3.PubMedCrossRef
123.
Rex D, Duckworth WC. Remission of overt diabetes mellitus after removal of an oral epidermoid carcinoma. Am J Med Sci. 1984;287(3):43–5.PubMedCrossRef
124.
Ricard D, Soussain C, Psimaras D. Neurotoxicity of the CNS: diagnosis, treatment and prevention. Rev Neurol (Paris). 2011;167(10):737–45.CrossRef
125.
Hamilton RB, Norgren R. Central projections of gustatory nerves in the rat. J Comp Neurol. 1984;222(4):560–77.PubMedCrossRef
126.
Jang HJ, Kokrashvili Z, Theodorakis MJ, et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci U S A. 2007;104(38):15069–74.PubMedPubMedCentralCrossRef
127.
Torii K, Uneyama H, Nakamura E. Physiological roles of dietary glutamate signaling via gut-brain axis due to efficient digestion and absorption. J Gastroenterol. 2013;48(4):442–51.PubMedPubMedCentralCrossRef
128.
Niijima A. Effect of umami taste stimulations on vagal efferent activity in the rat. Brain Res Bull. 1991;27(3–4):393–6.PubMedCrossRef
129.
Schier LA, Davidson TL, Powley TL. Rapid stimulus-bound suppression of intake in response to an intraduodenal nonnutritive sweetener after training with nutritive sugars predicting malaise. Am J Physiol Regul Integr Comp Physiol. 2012;302(11):R1351–63.PubMedPubMedCentralCrossRef
130.
Freeman AJ, Cunningham KT, Tyers MB. Selectivity of 5-HT3 antagonists and anti-emetic mechanisms of action. Anti-Cancer Drugs. 1992;3(2):79–85.PubMedCrossRef
131.
Wood PL. The NMDA receptor complex: a long and winding road to therapeutics. IDrugs. 2005;8(3):229–35.PubMed
132.
Vyklicky V, Korinek M, Smejkalova T, et al. Structure, function, and pharmacology of NMDA receptor channels. Physiol Res. 2014;63(Suppl 1):S191–203.PubMed
133.
Metadaten
Titel
The Role of the Vagal Nucleus Tractus Solitarius in the Therapeutic Effects of Obesity Surgery and Other Interventional Therapies on Type 2 Diabetes
verfasst von
Claudio Blasi
Publikationsdatum
11.10.2016
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 12/2016
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-016-2419-2

Weitere Artikel der Ausgabe 12/2016

Obesity Surgery 12/2016 Zur Ausgabe

Original Contributions

Comparison Between Different Intramuscular Vitamin B12 Supplementation Regimes: a Retrospective Matched Cohort Study

Original Contributions

Perioperative Risks of Untreated Obstructive Sleep Apnea in the Bariatric Surgery Patient: a Retrospective Study

Biography

Biography of Rudolf A. Weiner, MD, PhD

Letter to the Editor/LED Reply

Postoperative Bleeding and Leakage After Sleeve Gastrectomy: a Single-Center Experience

Original Contributions

Physical Activity, Decision-Making Abilities, and Eating Disturbances in Pre- and Postbariatric Surgery Patients

Original Contributions

Formal Nutritional Education Improves Weight Loss in Bariatric Patients Following Laparoscopic Sleeve Gastrectomy

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.